MXPA02004627A - Vacunas contra el micoplasma bovis y sus metodos de uso. - Google Patents
Vacunas contra el micoplasma bovis y sus metodos de uso.Info
- Publication number
- MXPA02004627A MXPA02004627A MXPA02004627A MXPA02004627A MXPA02004627A MX PA02004627 A MXPA02004627 A MX PA02004627A MX PA02004627 A MXPA02004627 A MX PA02004627A MX PA02004627 A MXPA02004627 A MX PA02004627A MX PA02004627 A MXPA02004627 A MX PA02004627A
- Authority
- MX
- Mexico
- Prior art keywords
- bovis
- vaccines
- infections
- novel
- mycoplasma bovis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Abstract
Se describe una invencion novedosa de vacunas efectivas en contra del Microplasma bovis para usarse en el ganado. Estas vacunas demuestran efectos colaterales no deseables y protectores en contra de la enfermedad relacionada con el M. bovis, tales como mastitis contagiosa, neumonia respiratoria, infecciones conjuntas, ceratoconjuntivitis e infecciones del oido medio. Las vacunas novedosas tambien disminuyen el efecto de las infecciones M. bovis en la produccion de leche, en la ganancia del peso y la salud del animal. Tambien se describen los metodos de diagnostico, la caracterizacion y tratamiento de las infecciones M. bovis como biotipos especificos. Las composiciones de las vacunas realizadas de conformidad con la invencion pueden ser de variedad atenuada o inactivada. Las vacunas tambien pueden incluir antigenos de otros patogenos de manera que proporcionen una respuesta inmunogenica protectora para las otras enfermedades diferentes a las causadas por el M. bovis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16428699P | 1999-11-08 | 1999-11-08 | |
PCT/US2000/042000 WO2001034189A2 (en) | 1999-11-08 | 2000-11-08 | Vaccines for mycoplasma bovis and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02004627A true MXPA02004627A (es) | 2004-02-18 |
Family
ID=22593810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02004627A MXPA02004627A (es) | 1999-11-08 | 2000-11-08 | Vacunas contra el micoplasma bovis y sus metodos de uso. |
Country Status (10)
Country | Link |
---|---|
US (7) | US7943153B1 (es) |
EP (1) | EP1229929A2 (es) |
JP (1) | JP2003513935A (es) |
AU (1) | AU782508B2 (es) |
BR (1) | BR0015398A (es) |
CA (1) | CA2390613A1 (es) |
IL (1) | IL149471A0 (es) |
MX (1) | MXPA02004627A (es) |
WO (1) | WO2001034189A2 (es) |
ZA (1) | ZA200203622B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL149471A0 (en) * | 1999-11-08 | 2002-11-10 | Biomune | Vaccines for mycoplasma bovis and methods for immunizing bovine amimals |
GB0110851D0 (en) * | 2001-05-03 | 2001-06-27 | Mini Agriculture & Fisheries | Vaccine |
US20030147914A1 (en) * | 2001-07-02 | 2003-08-07 | Pfizer Inc. | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
RU2004105962A (ru) * | 2001-08-28 | 2005-03-27 | Пфайзер Продактс Инк. (Us) | Модель инфицирования mycoplasma bovis, способы введения m. bovis и способы индуцирования пневмонических повреждений легких |
EP2121721A4 (en) * | 2006-09-07 | 2010-10-06 | Boehringer Ingelheim Vetmed | GENOTYPING BASED ON PCR |
AR069087A1 (es) * | 2007-10-29 | 2009-12-30 | Boehringer Ingelheim Vetmed | Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma |
MX2010005014A (es) * | 2007-11-06 | 2010-06-30 | Wyeth Llc | Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante. |
EP2163239A1 (de) * | 2008-05-27 | 2010-03-17 | Qiagen GmbH | Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung |
CA2729080C (en) * | 2008-07-03 | 2018-09-11 | Ricardo Rosenbusch | Cattle vaccines |
CA2740954C (en) * | 2008-10-31 | 2018-09-25 | Boehringer Ingelheim Vetmedica, Inc. | Multivalent vaccine composition |
UY32570A (es) * | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
CA2764424C (en) | 2009-06-04 | 2019-12-31 | National Institute Of Advanced Industrial Science And Technology | Vaccine for mycoplasma infection |
US9827299B2 (en) | 2009-10-09 | 2017-11-28 | Children's Medical Center Corporation | Selectively disrupted whole-cell vaccine |
WO2012041635A1 (en) * | 2010-09-29 | 2012-04-05 | Universite De Liege | Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis |
US9052315B2 (en) | 2012-05-09 | 2015-06-09 | Advanced Animal Diagnostics, Inc. | Rapid detection of analytes in liquid samples |
US10359614B2 (en) | 2012-07-03 | 2019-07-23 | Advanced Animal Diagnostics, Inc. | Diagnostic apparatus |
HUE059179T2 (hu) | 2012-09-10 | 2022-10-28 | Galenbio Inc | Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag |
US9797893B2 (en) | 2013-05-09 | 2017-10-24 | Advanced Animal Diagnostics, Inc. | Rapid detection of analytes in liquid samples |
BR112018002919B1 (pt) | 2015-08-14 | 2024-02-27 | Zoetis Services Llc | Composição imunogênica eficaz compreendendo uma cepa de mycoplasma bovis e usos da mesma para prevenção de doenças causadas por mycoplasma bovis |
CN110338138B (zh) * | 2019-06-19 | 2021-04-06 | 山东省农业科学院奶牛研究中心 | 一种牛支原体感染豚鼠的动物模型构建方法及其应用 |
CN113040094B (zh) * | 2021-03-18 | 2022-06-21 | 中国农业大学 | 一种牛支原体性小鼠乳腺炎模型的构建方法及其应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA814386B (en) | 1980-07-01 | 1982-07-28 | Nat Res Dev | Production of viral antigens |
US4425330A (en) * | 1981-05-20 | 1984-01-10 | Cornell Research Foundation, Inc. | Bovine mastitis vaccine and method for detecting efficacy thereof |
US4517394A (en) * | 1983-07-05 | 1985-05-14 | W. R. Grace & Co. | Preparation of nitro compounds by vapor phase nitration of carboxylic acids |
US5178860A (en) | 1989-09-01 | 1993-01-12 | Coopers Animal Health Limited | Adjuvant complexes and vaccine made therefrom |
US4981684A (en) | 1989-10-24 | 1991-01-01 | Coopers Animal Health Limited | Formation of adjuvant complexes |
US5565205A (en) | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
CA2057946A1 (en) * | 1990-12-20 | 1992-06-21 | Michael M. Thackeray | Electrochemical cell |
US5316875A (en) * | 1991-07-19 | 1994-05-31 | Matsushita Electric Industrial Co., Ltd. | Secondary battery with nonaqueous electrolyte and method of manufacturing same |
US5338543A (en) | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
US5585098A (en) | 1993-11-23 | 1996-12-17 | Ovimmune, Inc. | Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants |
WO1995022314A1 (en) * | 1994-02-18 | 1995-08-24 | Innovac Co. | Inoculation of animals with dried, pelleted biological materials |
JP3702353B2 (ja) * | 1996-05-24 | 2005-10-05 | 日本電池株式会社 | リチウム電池用正極活物質の製造方法およびリチウム電池 |
IL149471A0 (en) * | 1999-11-08 | 2002-11-10 | Biomune | Vaccines for mycoplasma bovis and methods for immunizing bovine amimals |
DE29921392U1 (de) * | 1999-12-06 | 2000-03-16 | Felgentraeger & Co Oeko Chem U | Mykoplasma-bovis-Kombinations-Vakzine für Rinder |
US6680143B2 (en) * | 2000-06-22 | 2004-01-20 | The University Of Chicago | Lithium metal oxide electrodes for lithium cells and batteries |
US6677082B2 (en) * | 2000-06-22 | 2004-01-13 | The University Of Chicago | Lithium metal oxide electrodes for lithium cells and batteries |
JP3500424B2 (ja) * | 2000-08-31 | 2004-02-23 | 独立行政法人産業技術総合研究所 | 単相リチウムフェライト系複合酸化物 |
US6548069B2 (en) | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
-
2000
- 2000-11-08 IL IL14947100A patent/IL149471A0/xx unknown
- 2000-11-08 JP JP2001536186A patent/JP2003513935A/ja active Pending
- 2000-11-08 MX MXPA02004627A patent/MXPA02004627A/es not_active Application Discontinuation
- 2000-11-08 EP EP00989763A patent/EP1229929A2/en not_active Withdrawn
- 2000-11-08 AU AU26225/01A patent/AU782508B2/en not_active Ceased
- 2000-11-08 WO PCT/US2000/042000 patent/WO2001034189A2/en active IP Right Grant
- 2000-11-08 CA CA002390613A patent/CA2390613A1/en not_active Abandoned
- 2000-11-08 BR BR0015398-2A patent/BR0015398A/pt not_active Application Discontinuation
- 2000-11-08 US US09/708,352 patent/US7943153B1/en not_active Expired - Fee Related
-
2002
- 2002-05-07 ZA ZA200203622A patent/ZA200203622B/en unknown
-
2003
- 2003-12-01 US US10/726,029 patent/US7429389B2/en not_active Expired - Fee Related
-
2004
- 2004-04-14 US US10/825,391 patent/US7416734B2/en not_active Expired - Fee Related
-
2006
- 2006-07-18 US US11/489,147 patent/US20070077260A1/en not_active Abandoned
-
2007
- 2007-10-31 US US11/982,079 patent/US20090220550A1/en not_active Abandoned
- 2007-10-31 US US11/982,082 patent/US20090263427A1/en not_active Abandoned
- 2007-10-31 US US11/982,265 patent/US20080226671A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BR0015398A (pt) | 2002-06-25 |
US20090263427A1 (en) | 2009-10-22 |
US20080226671A1 (en) | 2008-09-18 |
WO2001034189A2 (en) | 2001-05-17 |
US7416734B2 (en) | 2008-08-26 |
EP1229929A2 (en) | 2002-08-14 |
US20070077260A1 (en) | 2007-04-05 |
US20050118200A1 (en) | 2005-06-02 |
WO2001034189A3 (en) | 2001-12-27 |
US20050053627A1 (en) | 2005-03-10 |
US20090220550A1 (en) | 2009-09-03 |
US7943153B1 (en) | 2011-05-17 |
IL149471A0 (en) | 2002-11-10 |
JP2003513935A (ja) | 2003-04-15 |
AU2622501A (en) | 2001-06-06 |
US7429389B2 (en) | 2008-09-30 |
US20080069842A9 (en) | 2008-03-20 |
AU782508B2 (en) | 2005-08-04 |
CA2390613A1 (en) | 2001-05-17 |
ZA200203622B (en) | 2003-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02004627A (es) | Vacunas contra el micoplasma bovis y sus metodos de uso. | |
MX9702955A (es) | Vacuna y antitoxina para tratamiento y prevencion de enfermedad c. difficile. | |
EP1854886A3 (en) | Cold-adapted equine influenza viruses | |
Koprowski et al. | Propagation of hog cholera virus in rabbits | |
US20210030862A1 (en) | A vaccine for protection against streptococcus suis | |
BG108496A (en) | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals | |
JP2003513935A5 (es) | ||
WO2001060849A3 (en) | Cold-adapted equine influenza viruses | |
US11696944B2 (en) | Vaccine for protection against Streptococcus suis | |
EP3661546B1 (en) | A vaccine for protection against streptococcus suis | |
WO1999053950A3 (en) | Live vaccines and methods of treatment therewith | |
US20130064852A1 (en) | Vaccine against mycoplasma, hyopneumoniae, suitable for administration in the presence of maternally derived antibodies | |
JP2013501028A (ja) | 豚胸膜肺炎に対するワクチン及び当該ワクチンの取得方法 | |
WO2001074386A3 (en) | Cold-adapted equine influenza viruses | |
JP2021506777A (ja) | レンサ球菌感染防御のためのワクチン | |
EP1858550B1 (en) | Vaccine formulation | |
HUP9700975A2 (hu) | Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok | |
KR100766775B1 (ko) | 장출혈성대장균(ehec) 감염증 예방용 톡소이드 백신 | |
JP2017525726A5 (es) | ||
Blackmore et al. | Alternative strategies for the control of leptospirosis in dairy herds | |
RU2802072C2 (ru) | Вакцина для защиты от streptococcus suis | |
IL122829A (en) | Isolated strains of staphylococcus aureus and vaccines manufactured therefrom | |
Gatewood et al. | Evaluation of type II killed BVD vaccine in the face of type II BVD challenge | |
O’Connell et al. | The development and testing of a vaccine for the prevention of infectious bovine keratoconjuctivitis | |
UA67249A (en) | Strain paramixovirus-3 bovis "m-87" for the preparation of vaccine and diagnostic antigen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |